This inventor holds 4 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2003-2013.
Company Filing History:
Years Active: 2003-2013
Title: Marco Schroeder: Innovator in Pharmaceutical Compositions
Introduction
Marco Schroeder is a notable inventor based in Schopfheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that inhibit lipase, an enzyme involved in fat digestion. With a total of 4 patents to his name, Schroeder's work is aimed at addressing obesity through innovative solutions.
Latest Patents
Among his latest patents, Schroeder has developed a lipase inhibiting composition. This pharmaceutical composition contains a lipase inhibitor with a melting point of ≥37°C, along with a sucrose fatty acid ester that can be a mono-, di-, tri-, or tetra-ester. Additionally, the composition may include one or more pharmaceutically acceptable excipients, making it useful for the treatment of obesity.
Career Highlights
Marco Schroeder is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work focuses on creating effective treatments that can help manage obesity, showcasing his commitment to improving public health through innovation.
Collaborations
Throughout his career, Schroeder has collaborated with notable colleagues, including Lukas Christoph Scheibler and Rainer Eugen Martin. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Marco Schroeder stands out as an influential inventor in the pharmaceutical sector, particularly with his innovative approaches to treating obesity. His contributions through patents and collaborations reflect his dedication to advancing medical science and improving health outcomes.